Global strategy for asthma management and prevention: GINA executive summary
Tóm tắt
Asthma is a serious health problem throughout the world. During the past two decades, many scientific advances have improved our understanding of asthma and ability to manage and control it effectively. However, recommendations for asthma care need to be adapted to local conditions, resources and services. Since it was formed in 1993, the Global Initiative for Asthma, a network of individuals, organisations and public health officials, has played a leading role in disseminating information about the care of patients with asthma based on a process of continuous review of published scientific investigations. A comprehensive workshop report entitled “A Global Strategy for Asthma Management and Prevention”, first published in 1995, has been widely adopted, translated and reproduced, and forms the basis for many national guidelines. The 2006 report contains important new themes. First, it asserts that “it is reasonable to expect that in most patients with asthma, control of the disease can and should be achieved and maintained,” and recommends a change in approach to asthma management, with asthma control, rather than asthma severity, being the focus of treatment decisions. The importance of the patient–care giver partnership and guided self-management, along with setting goals for treatment, are also emphasised.
Từ khóa
Tài liệu tham khảo
Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA), 2002. Available from www.ginasthma.org Date last updated. 2002
Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA), 2006. Available from www.ginasthma.org Date last updated. 2006
Global Initiative for Asthma (GINA). Documents available from www.ginasthma.org
Beasley R The Global Burden of Asthma Report; Global Initiative for Asthma (GINA) www.ginasthma.org/ReportItem.asp?l1 = 2&l2 = 2&intId = 94 Date last updated. 2004
2007, Arch Bronconeumol, 43, 425
2006, Lancet, 268, 733
1993, Eur Respir J Suppl, 16, 1
Measurement of health-related quality of life. Adult asthma. www.qoltech.co.uk/asthma1.htm Date last updated: November, 2006. Date last accessed: July 15, 2007.
American Lung Association. Take the asthma control test and share the results with your doctor. www.asthmacontrol.com Date last updated: January 8, 2001. Date last accessed: July 15, 2007.
ATAQ Instrument. Asthma Therapy Assessment Questionnaire. www.ATAQInstrument.com Date last updated: 2006. Date last accessed, July 15, 2007.
National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Bethesda, National Heart, Lung, and Blood Institute, National Institutes of Health, 1997
2005, J Rheumatol, 32, 1076
US Food and Drug Administration. Advair Diskus, Advair HFA, Brovana, Foradil, Serevent Diskus, and Symbicort Information (Long Acting Beta Agonists) www.fda.gov/cder/drug/infopage/LABA/default.htm Date last updated: October 16, 2006. Date last accessed. November 15, 2006
About Health Canada. Safety information about a class of asthma drugs known as long-acting β2 agonists www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2005/2005_107_e.html Date last updated: September 12, 2003. Date last accessed: November 15, 2006.
Wilson AJ, Gibson PG, Coughlan J. Long acting β-agonists versus theophylline for maintenance treatment of asthma. Cochrane Database Syst Rev 2000; CD001281
Davies H, Olson L, Gibson P. Methotrexate as a steroid sparing agent for asthma in adults. Cochrane Database Syst Rev 2000; CD000391
Richeldi L, Ferrara G, Fabbri L, Lasserson T, Gibson P. Macrolides for chronic asthma. Cochrane Database Syst Rev 2005; CD002997
Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003; CD001186
Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for β-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006; CD000052
Adams NP, Bestall JB, Malouf R, Lasserson TJ, Jones PW. Inhaled beclomethasone versus placebo for chronic asthma. Cochrane Database Syst Rev 2005; CD002738
Adams NP, Bestall JC, Jones PW, Lasserson TJ, Griffiths B, Cates C. Inhaled fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev 2005; CD003534
1997, Allergy, 52, 1
Powell H, Gibson PG. High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children. Cochrane Database Syst Rev 2004; CD004109
Pedersen S. Do inhaled corticosteroids inhibit growth in children? Am J Respir Crit Care Med. 2001;164:521–535.
Sharek PJ, Bergman DA. Beclomethasone for asthma in children: effects on linear growth. Cochrane Database Syst Rev 2000; CD001282
1995, Ann Allergy Asthma Immunol, 75, 143
Shaw L, al-Dlaigan YH, Smith A. Childhood asthma and dental erosion. ASDC J Dent Child 2000; 67 102–106:182
1998, J Clin Pediatr Dent, 22, 137
Ng D, Salvio F, Hicks G. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev 2004; CD002314
1988, Am J Med, 85, 17
1984, Eur J Respir Dis Suppl, 134, 205
McDonald NJ, Bara AI. Anticholinergic therapy for chronic asthma in children over two years of age. Cochrane Database Syst Rev 2003; CD003535
1995, Monaldi Arch Chest Dis, 50, 398
Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003; CD001117
Gibson PG, Powell H, Coughlan J, et al. Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev 2002; CD001005
Haby MM, Waters E, Robertson CF, Gibson PG, Ducharme FM. Interventions for educating children who have attended the emergency room for asthma. Cochrane Database Syst Rev 2001; CD001290
Powell H, Gibson PG. Options for self-management education for adults with asthma. Cochrane Database Syst Rev 2003; CD004107
1995, CMAJ, 152, 1423
Asthma UK. www.asthma.org.uk Date last updated: November 2, 2007. Date last accessed: November 15, 2006.
National Heart, Lung, and Blood Institute. Asthma Management Model System. www.nhlbisupport.com/asthma/index.html Date last updated: July, 2007. Date last accessed: July 15, 2007.
Asthma and Respiratory Foundation, New Zealand. www.asthmanz.co.nz Date last updated: 2007. Date last accessed: July 15, 2007.
Gotzsche PC, Johansen HK, Schmidt LM, Burr ML. House dust mite control measures for asthma. Cochrane Database Syst Rev 2004; CD001187
Cates CJ, Jefferson TO, Bara AI, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev 2004; CD000364
Chien S, Mintz S. Pregnancy and menses. In: Weiss EB, Stein M, eds. Bronchial Asthma Mechanisms and Therapeutics. Boston, Little Brown, 1993; pp. 1085–1098
Spooner CH, Saunders LD, Rowe BH. Nedocromil sodium for preventing exercise-induced bronchoconstriction. Cochrane Database Syst Rev 2000; CD001183
Ram FS, Robinson SM, Black PN. Physical training for asthma. Cochrane Database Syst Rev 2000; CD001116
Ostergaard P, Pedersen S. The effect of inhaled disodium cromoglycate and budesonide on bronchial responsiveness to histamine and exercise in asthmatic children: a clinical comparison. In: Godfrey S, ed. Glucocorticosteroids in Childhood Asthma. New York, Elsevier Science Publishing Co., 1987; pp. 55–65
Cates CC, Bara A, Crilly JA, Rowe BH. Holding chambers versus nebulisers for β-agonist treatment of acute asthma. Cochrane Database Syst Rev 2003; CD000052
Mash B, Bheekie A, Jones PW. Inhaled versus oral steroids for adults with chronic asthma. Cochrane Database Syst Rev 2000; CD002160
FitzGerald JM, Grunfeld A. Status asthmaticus. In: Lichtenstein LM, Fauci AS, eds. Current Therapy in Allergy, Immunology, and Rheumatology. 5th Edn. St Louis, Mosby, 1996; pp. 63–67
1996, Br J Hosp Med, 55, 253
FitzGerald JM. Development and implementation of asthma guidelines. Can Respir J 1998; 5: Suppl. A, 85S–88S
2000, Clin Evidence, 3, 686
1995, Ann Allergy Asthma Immunol, 75, 41
Travers A, Jones AP, Kelly K, Barker SJ, Camargo CA, Rowe BH. Intravenous β2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev 2001; CD002988
Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline to β2-agonists in adults with acute asthma. Cochrane Database Syst Rev 2000; CD002742
Manser R, Reid D, Abramson M. Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev 2000; CD001740
1986, Lancet, 1, 181
Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2000; CD002178
Edmonds ML, Camargo CA, Saunders LD, Brenner BE, Rowe BH. Inhaled steroids in acute asthma following emergency department discharge (Cochrane review). Cochrane Database Syst Rev 2000; CD002316
Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA Jr. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000; CD001490
Blitz M, Blitz S, Beasely R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev 2005:CD003898
Gibson PG, Coughlan J, Wilson AJ, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2000; CD001117
1995, Am J Respir Crit Care Med, 151, 1170
1984, Anesth Analg, 63, 844
Allergic Rhinitis and its Impact on Asthma (ARIA). www.whiar.com Date last accessed: July 15, 2007.
Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI. Definition and classification of asthma. In: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI, eds. Asthma in the Workplace. New York, Marcel Dekker, 1999; pp. 1–4
British Occupational Health Research Foundation. www.bohrf.org.uk/downloads/asthevre.pdf Date last accessed: July 15, 2007.
Gern JE, Lemanske RF Jr. Infectious triggers of pediatric asthma. Pediatr Clin North Am 2003; 50 555–575:vi
Busse WW. The role of respiratory viruses in asthma. In: Holgate S, ed. Asthma: Physiology, Immunopharmcology and Treatment. London, Academic Press, 1993; pp. 345–352
Sontag SJ. Why do the published data fail to clarify the relationship between gastroesophageal reflux and asthma? Am J Med 2000; 108: Suppl. 4A, 159S–169S
National Asthma Council, Australia. www.nationalasthma.org.au Date last updated: November 6, 2007. Date last accessed: July 15, 2007.
Global Alliance against Chronic Respiratory Diseases (GARD) www.who.int/respiratory/gard/en/ Date last updated:. 2007. Date last accessed: July 15, 2007.